4 ms·
Some elderly friends have asked why Britain is opting to use a brand new RNA/nanotechnololgy style vaccine (which has never been approved before) and is only ~9
by irthomasthomas 6y ago
Some elderly friends have asked why Britain is opting to use a brand new RNA/nanotechnololgy style vaccine (which has never been approved before) and is only ~94% effective, when there is a traditional inactivated vaccine that is 100% effective? I presume Pfizer simply have better lobying, but given the choice, I would rather go with old-fashioned sinovac https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30843-4/fulltext https://www.thelancet.com/journals/laninf/article/PIIS1473-3...
- ciarannolan 6y ago> only ~94% effective Lol.
- TedPetrou 6y agoNo one was deliberately inoculated with the virus and only symptomatic people were tested. 99.96% of the placebo group did not have a severe case of covid. There is no way to determine effectiveness from this trial.
- cpncrunch 6y agoTypically flu vaccine is 67% effective, which is similar to the AstraZeneca COVID vaccine.
- awssucs 6y agoastra zeneca is 90% effective as there are two doses needed, much like pfizers
- amanaplanacanal 6y agoIt appears that phase 3 trials haven’t started yet in that vaccine. I would expect it to be several months before it is ready to submit.